Quality From the Start: Preparing for a Successful Transition From Late Stage Discovery to the Clinic

Sponsored content for Lonza Pharma & Biotech by BioPharma Dive's Brand Studio

WEBINAR ON DEMAND
Duration: 1 hour


Advancing an innovative drug from late stage discovery into the clinic is the most-critical step in drug product development. While drug developers would like to gain as much information on the product as possible, the scientific focus must be on the drug design for optimal efficacy and safety at this stage.

This is when key decisions are made that have a long-term impact and pave the way for clinical and commercial manufacturing as well as the future supply chain. In this early phase, it is less about speed, and more important to focus on quality from the start. During this webinar, we will discuss and discover:

  • What pitfalls to avoid in order to seamlessly advance a new drug from late stage discovery into clinic
  • How to efficiently manage the manufacturing process
  • Ways to reduce time into clinic and equip drug candidates with a robust CMC-package
  • How to add value as you advance from one clinical phase to the next and are looking for investors and partners
     

SPEAKERS  

Abdelaziz Toumi, PhD
Senior Director, Head of Commercial Solutions 
Ibex™ Design & Develop
Lonza Pharma & Biotech


Noel Smith, PhD
Head of Immunology, Applied Protein Services
Lonza Pharma & Biotech

WATCH NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2020 Industry Dive | Privacy Policy | Terms of Use